Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 21:2020:6345429.
doi: 10.1155/2020/6345429. eCollection 2020.

Bioactivity and Molecular Docking Studies of Derivatives from Cinnamic and Benzoic Acids

Affiliations

Bioactivity and Molecular Docking Studies of Derivatives from Cinnamic and Benzoic Acids

Yunierkis Perez-Castillo et al. Biomed Res Int. .

Abstract

Over the last decade, there has been a dramatic increase in the prevalence and gravity of systemic fungal diseases. This study aimed therefore at evaluating the antifungal potential of ester derivatives of benzoic and cinnamic acids from three Candida species. The compounds were prepared via Fischer esterification, and the antifungal assay was performed by the microdilution method in 96-well microplates for determining the minimal inhibitory concentrations (MICs). The findings of the antifungal tests revealed that the analogue compound methyl ferulate, methyl o-coumarate, and methyl biphenyl-3-carboxylate displayed an interesting antifungal activity against all Candida strains tested, with MIC values of 31.25-62.5, 62.5-125, and 62.5 μg/ml, respectively. A preliminary Structure-Activity Relationship study of benzoic and cinnamic acid derivatives has led to the recognition of some important structural requirements for antifungal activity. The results of molecular docking indicate that the presence of the enoate moiety along with hydroxyl and one methoxy substitution in the phenyl ring has a positive effect on the bioactivity of compound 7 against Candida albicans. These observations further support the hypothesis that the antifungal activity of compound 7 could be due to its binding to multiple targets, specifically to QR, TS, and ST-PK. Additional experiments are required in the future to test this hypothesis and to propose novel compounds with improved antifungal activity.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the authors.

Figures

Figure 1
Figure 1
Chemical structures of the evaluated compounds.
Figure 2
Figure 2
Predicted binding modes of compound 7 to ST-PK (a), TS (b), and QR (c) of Candida albicans (left). Compound 7 is depicted cyan and the receptors in gray, with noncarbon atoms following the scheme: blue for N, red for O, yellow for S, white for H, and orange for P. On the right side of the figure are represented the predicted interaction frequencies with the residues at the receptors binding sites. Darker lines indicate the higher frequencies of interaction. Only residues interacting with the ligand in more than 50% of the analyzed MD snapshots are labelled in the complexes' structures.
Figure 3
Figure 3
Predicted binding modes of compounds 7, 2, and 22 to QR, TS, and ST-PK of Candida albicans. Compounds are depicted cyan and the receptors in gray, with noncarbon atoms following the scheme: blue for N, red for O, yellow for S, and orange for P. Only residues interacting with the ligand in more than 50% of the analyzed MD snapshots are labelled in the complexes' structures. The complexes with each receptor were superimposed before generating the images.

References

    1. Wang W., Dong G., Gu J., et al. Structure–activity relationships of tetrahydrocarbazole derivatives as antifungal lead compounds. Medicinal Chemistry Communications. 2013;4(2):353–362. doi: 10.1039/C2MD20211E. - DOI
    1. Rusu E., Radu-Popescu M., Pelinescu D., Vassu T. Treatment with some anti-inflammatory drugs reduces germ tube formation in Candida albicans strains. Brazilian Journal of Microbiology. 2014;45(4):1379–1383. doi: 10.1590/S1517-83822014000400031. - DOI - PMC - PubMed
    1. Babu K. S., Li X. C., Jacob M. R., et al. Synthesis, antifungal activity, and structure-activity relationships of Coruscanone A analogues. Journal of Medicinal Chemistry. 2006;49(26):7877–7886. doi: 10.1021/jm061123i. - DOI - PMC - PubMed
    1. Sharanappa R., Vidyasagar G. M. Anti-Candida activity of medicinal plants: a review. International Journal Pharmacy and Pharmaceutial Sciences. 2013;5(4):9–16.
    1. Papon N., Courdavault V., Clastre M., Bennett R. J. Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm. PLOS Pathogens. 2013;9(9, article e1003550) doi: 10.1371/journal.ppat.1003550. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources